Learning Objectives:

1.  Identify genetic bases for reliance on PD-1 signaling in Hodgkin lymphoma and other lymphoid malignancies

2.  Identify additional genetic mechanisms of immune evasion in these tumors.

3. Utilize the information from #1 and #2 to develop ore effective combination therapies.

Session date: 
10/25/2021 - 12:00pm to 1:00pm CDT
United States
  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 Participation

Please login or create an account to proceed.
Speaker Name: 
Margaret Shipp, MD